From: Engagement of the private pharmaceutical sector for TB control: rhetoric or reality?
Country | Year | Number of retail drug outlets | Number of referrals | % screened among referrals | Smear-positive cases |
---|---|---|---|---|---|
Vietnam | 2003 | 150 | 310 | 48% (149) | 10 |
Bolivia | 2005 | 70 | 41 | 27% (11) | 3 |
Philippines | 2005 | no data | 2,334 | no data | no data |
Philippines | 2005 | no data | 1,550 | 37% (575) | 83 |
Cambodia | 2008 | 683 | 4,230 | 79% (3,356) | 1,769 |
India (Tamil Nadu) | 2010 | 402 | 101 | no data | no data |
Philippines | 2011 | 119 | 942 | 11% (99) | 14 |
India (2 cities) | 2012 | 80 | 23 | No data | 8 |
Burkina Faso | 2013 | 131 | 821 | 44% (361) | 17 |
India (Andhra Pradesh) | 2013 | 60 | 117 | 89% (104) | 6 |
Myanmar | 2013 | 99 | 224 | 65% (145) | 18 |
India (Tamil Nadu) | 2014 | 550 | 382 | 66% (252) | 130 |
India (Andhra Pradesh) | 2014 | 177 | 871 | 91% (792) | 90 |
Myanmar | 2014 | 212 | no data | no data | 53 |
Myanmar | 2014 | 263 | 2,335 | 86% (2,013) | 395 |